The role of serum lipids on cyclosporine-induced gingival overgrowth in renal transplant patients

Basit Öğe Kaydı
dc.contributor.authorIlgenli T.
dc.contributor.authorAtilla G.
dc.contributor.authorCirit M.
dc.contributor.authorAzmak N.
dc.date.accessioned2019-10-27T00:27:32Z
dc.date.available2019-10-27T00:27:32Z
dc.date.issued1999
dc.departmentEge Üniversitesien_US
dc.description.abstractCyclosporine-A (CsA) is widely used to prevent organ rejection in recipients of transplanted organs and also in the treatment of various systemic diseases. CsA has a number of side effects, including gingival overgrowth (GO). However, the pathogenesis of CsA-induced GO remains uncertain. It has been postulated that CsA alters fibroblast activity. CsA is transported in plasma by binding to lipid components. It is possible that changes in serum lipid levels could alter the interaction between the CsA and gingival fibroblasts within the gingival tissues. It has also been reported that CsA may alter serum lipid levels in the transplant population. The aim of this study was to investigate the relationship between the serum lipids and CsA-induced GO. A total of 47 renal transplant recipients receiving CsA, azathioprine and prednisolone were the subjects of this study. Periodontal measurements were taken including plaque index (PII) and GO scores (GO). GO was classified into four categories according to the clinical changes. The whole blood CsA concentration, serum total cholesterol, triglyceride and ceratinine levels, and duration of CsA therapy of these patients were obtained from the subject's medical records. These were assessed monthly. CsA-treated recipients were divided for statistical purposes into two groups according to their GO scores. The recipients having sites with clinically significant GO (scores of 2 and 3) were classified as respondents, and those without evidence of overgrowth (GO score=0) as non-responders. There were no differences in age, plaque scores, duration of CsA therapy, and azathioprine and prednisolone dosage between responders and non-responders. Similarly, no statistically significant differences in serum lipids and whole blood CsA concentration were found between these two groups. These data indicate that CsA-induced GO is unrelated to serum lipid components. To our knowledge, this is the first report describing the relationship between the serum lipids and CsA-induced GO. We believe that additional studies will be necessary for complete understanding of the mechanism of gingival overgrowth.en_US
dc.identifier.endpage301en_US
dc.identifier.issn1300-0144
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage297en_US
dc.identifier.urihttps://hdl.handle.net/11454/23540
dc.identifier.volume29en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCholesterolen_US
dc.subjectCyclosporine-Aen_US
dc.subjectGingival overgrowthen_US
dc.subjectRenal transplanten_US
dc.subjectTriglycerideen_US
dc.titleThe role of serum lipids on cyclosporine-induced gingival overgrowth in renal transplant patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu